-
1
-
-
0028923741
-
Heparin-induced thrombocytopenia
-
Chong BH. Heparin-induced thrombocytopenia. Br J Haematol 1995;89:431-9.
-
(1995)
Br J Haematol
, vol.89
, pp. 431-439
-
-
Chong, B.H.1
-
2
-
-
0029035681
-
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
-
Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
-
(1995)
N Engl J Med
, vol.332
, pp. 1330-1335
-
-
Warkentin, T.E.1
Levine, M.N.2
Hirsh, J.3
-
4
-
-
0024357798
-
Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets
-
Chong BH, Fawaz I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989;73:235-40.
-
(1989)
Br J Haematol
, vol.73
, pp. 235-240
-
-
Chong, B.H.1
Fawaz, I.2
Chesterman, C.N.3
Berndt, M.C.4
-
5
-
-
0027971564
-
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia
-
Warkentin TE, Hayward CP, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994;84:3691-9.
-
(1994)
Blood
, vol.84
, pp. 3691-3699
-
-
Warkentin, T.E.1
Hayward, C.P.2
Boshkov, L.K.3
-
6
-
-
0030281338
-
A 14-year study of heparin-induced thrombocytopenia
-
Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-7.
-
(1996)
Am J Med
, vol.101
, pp. 502-507
-
-
Warkentin, T.E.1
Kelton, J.G.2
-
8
-
-
0030983928
-
Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
-
Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 1997;56:12-6.
-
(1997)
Am J Hematol
, vol.56
, pp. 12-16
-
-
Nand, S.1
Wong, W.2
Yuen, B.3
Yetter, A.4
Schmulbach, E.5
Gross Fisher, S.6
-
9
-
-
0033029056
-
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
-
Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999;106:629-35.
-
(1999)
Am J Med
, vol.106
, pp. 629-635
-
-
Wallis, D.E.1
Workman, D.L.2
Lewis, B.E.3
Steen, L.4
Pifarre, R.5
Moran, J.F.6
-
10
-
-
0345369740
-
Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study
-
for the HIT investigators group
-
Greinacher A, Volpel H, Janssens U, et al., for the HIT investigators group. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999;99:73-80.
-
(1999)
Circulation
, vol.99
, pp. 73-80
-
-
Greinacher, A.1
Volpel, H.2
Janssens, U.3
-
11
-
-
0027442550
-
Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaron (Org 10172)
-
Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaron (Org 10172). Thromb Haemost 1993;70:554-61.
-
(1993)
Thromb Haemost
, vol.70
, pp. 554-561
-
-
Magnani, H.N.1
-
12
-
-
0033543081
-
Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia
-
for the Heparin-Associated Thrombocytopenia Study (HAT) investigators
-
Greinacher A, Janssens U, Berg G, et al., for the Heparin-Associated Thrombocytopenia Study (HAT) investigators. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999;100:587-93.
-
(1999)
Circulation
, vol.100
, pp. 587-593
-
-
Greinacher, A.1
Janssens, U.2
Berg, G.3
-
13
-
-
0026009696
-
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia
-
Demers C, Ginsberg JS, Brill-Edwards P, et al. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood 1991;78:2194-7.
-
(1991)
Blood
, vol.78
, pp. 2194-2197
-
-
Demers, C.1
Ginsberg, J.S.2
Brill-Edwards, P.3
-
14
-
-
0021262284
-
Heparin-induced thrombocytopenia
-
King D, Kelton JG. Heparin-induced thrombocytopenia. Ann Intern Med 1984;100:535-40.
-
(1984)
Ann Intern Med
, vol.100
, pp. 535-540
-
-
King, D.1
Kelton, J.G.2
-
15
-
-
0022362993
-
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY216)
-
Leroy J, Leclerc MH, Delahousse B, et al. Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY216). Semin Thromb Hemost 1985;11:326-9.
-
(1985)
Semin Thromb Hemost
, vol.11
, pp. 326-329
-
-
Leroy, J.1
Leclerc, M.H.2
Delahousse, B.3
-
16
-
-
45949103154
-
American College of Chest Physicians; treatment and prevention of heparin-induced thrombocytopenia: ACCP evidence-based clinical practice guidelines
-
Warkentin TE, Greinacher A, Koster A, Lincoff AM. American College of Chest Physicians; treatment and prevention of heparin-induced thrombocytopenia: ACCP evidence-based clinical practice guidelines. Chest 2008;133(suppl 6):340S-80S.
-
(2008)
Chest
, vol.133
, Issue.SUPPL. 6
-
-
Warkentin, T.E.1
Greinacher, A.2
Koster, A.3
Lincoff, A.M.4
-
17
-
-
0035836541
-
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia
-
Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001;103:1838-43.
-
(2001)
Circulation
, vol.103
, pp. 1838-1843
-
-
Lewis, B.E.1
Wallis, D.E.2
Berkowitz, S.D.3
-
18
-
-
0027517894
-
The weight-based heparin dosing nomogram compared with 'standard care' nomogram
-
Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with 'standard care' nomogram. Ann Intern Med 1993;119:874-81.
-
(1993)
Ann Intern Med
, vol.119
, pp. 874-881
-
-
Raschke, R.A.1
Reilly, B.M.2
Guidry, J.R.3
Fontana, J.R.4
Srinivas, S.5
-
19
-
-
0028897526
-
Appropriate use of heparin: Empiric vs. nomogram-based dosing
-
Gunnarsson PD, Sawyer WT, Montague D, Williams ML, Dupuis RE, Caiola SM. Appropriate use of heparin: empiric vs. nomogram-based dosing. Arch Intern Med 1995;155:526-32.
-
(1995)
Arch Intern Med
, vol.155
, pp. 526-532
-
-
Gunnarsson, P.D.1
Sawyer, W.T.2
Montague, D.3
Williams, M.L.4
Dupuis, R.E.5
Caiola, S.M.6
-
20
-
-
0034049121
-
The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
-
Swan SK, Hursting M. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 2000;20:318-29.
-
(2000)
Pharmacotherapy
, vol.20
, pp. 318-329
-
-
Swan, S.K.1
Hursting, M.2
-
21
-
-
0037765191
-
Argatroban dosing in patients with heparin-induced thrombocytopenia
-
DOI 10.1345/aph.1C443
-
Verme-Gibboney CN, Hursting MJ. Argatroban dosing in patients with heparin-induced thrombocytopenia. Ann Pharmacother 2003;37:970-5. DOI 10.1345/aph.1C443
-
(2003)
Ann Pharmacother
, vol.37
, pp. 970-975
-
-
Verme-Gibboney, C.N.1
Hursting, M.J.2
-
22
-
-
0033937140
-
Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects
-
Swan SK, St. Peter JV, Lambrecht LJ, Hursting MJ. Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects. Pharmacotherapy 2000;20:756-70.
-
(2000)
Pharmacotherapy
, vol.20
, pp. 756-770
-
-
Swan, S.K.1
St. Peter, J.V.2
Lambrecht, L.J.3
Hursting, M.J.4
-
24
-
-
0022980224
-
Pharmacokinetic studies of argipidine (MD -805) - protein binding and blood cell binding] Japanese
-
Tatsuno J, Komatsu T, Iida S. [Pharmacokinetic studies of argipidine (MD -805) - protein binding and blood cell binding] Japanese. Jpn Pharmacol Ther 1986;14(suppl 5):243-9.
-
(1986)
Jpn Pharmacol Ther
, vol.14
, Issue.SUPPL. 5
, pp. 243-249
-
-
Tatsuno, J.1
Komatsu, T.2
Iida, S.3
-
25
-
-
0037407491
-
Excessive argatroban anticoagulation for heparin-induced thrombocytopenia
-
DOI 10.1345/aph.1C187
-
Reichert MG, MacGregor DA, Kincaid EH, Dolinski SY. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia. Ann Pharmacother 2003;37:652-4. DOI 10.1345/aph.1C187
-
(2003)
Ann Pharmacother
, vol.37
, pp. 652-654
-
-
Reichert, M.G.1
MacGregor, D.A.2
Kincaid, E.H.3
Dolinski, S.Y.4
-
26
-
-
0041422394
-
Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
-
DOI 10.1345/aph.1D010
-
Dager WE, White RH. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD. Ann Pharmacother 2003;37:1232-6. DOI 10.1345/aph.1D010
-
(2003)
Ann Pharmacother
, vol.37
, pp. 1232-1236
-
-
Dager, W.E.1
White, R.H.2
-
27
-
-
1542346478
-
Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction
-
Williamson DR, Boulander I, Tardif M, Albert M, Gregoire G. Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction. Pharmacotherapy 2004;24:409-14.
-
(2004)
Pharmacotherapy
, vol.24
, pp. 409-414
-
-
Williamson, D.R.1
Boulander, I.2
Tardif, M.3
Albert, M.4
Gregoire, G.5
-
28
-
-
18844400887
-
Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer
-
Epub 10 May, DOI 10.1345/aph.1G020
-
Kubiak DW, Szumita PM, Fanikos JR. Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer. Ann Pharmacother 2005;39:1119-23. Epub 10 May 2005. DOI 10.1345/aph.1G020
-
(2005)
Ann Pharmacother 2005
, vol.39
, pp. 1119-1123
-
-
Kubiak, D.W.1
Szumita, P.M.2
Fanikos, J.R.3
-
29
-
-
41149173180
-
Reduced argatroban doses after coronary artery bypass graft surgery
-
Epub 26 Feb, DOI 10.1345/aph.1K434
-
Hoffman WD, Czyz Y, McCollum DA, Hursting MJ. Reduced argatroban doses after coronary artery bypass graft surgery. Ann Pharmacother 2008;42:309-16. Epub 26 Feb 2008. DOI 10.1345/aph.1K434
-
(2008)
Ann Pharmacother 2008
, vol.42
, pp. 309-316
-
-
Hoffman, W.D.1
Czyz, Y.2
McCollum, D.A.3
Hursting, M.J.4
-
30
-
-
85069138737
-
-
Data on file. NDA submission, integrated summary of safety, Section 8, Table 8, demography of patients who participated in open-labeled studies. Includes Studies ARG-216m 240, 310, 911, 915. Texas Biotechnology Corporation, Houston, TX. Philadelphia, PA: GSK Pharmaceuticals.
-
Data on file. NDA submission, integrated summary of safety, Section 8, Table 8, demography of patients who participated in open-labeled studies. Includes Studies ARG-216m 240, 310, 911, 915. Texas Biotechnology Corporation, Houston, TX. Philadelphia, PA: GSK Pharmaceuticals.
-
-
-
-
31
-
-
34447620068
-
Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia
-
Rice L, Hursting MJ, Baillie GM, McCollum DA. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia. J Clin Pharmacol 2007;47:1028-34.
-
(2007)
J Clin Pharmacol
, vol.47
, pp. 1028-1034
-
-
Rice, L.1
Hursting, M.J.2
Baillie, G.M.3
McCollum, D.A.4
-
32
-
-
0023003183
-
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
-
Hull RD, Raskob GE, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-14.
-
(1986)
N Engl J Med
, vol.315
, pp. 1109-1114
-
-
Hull, R.D.1
Raskob, G.E.2
Hirsh, J.3
-
33
-
-
0019196280
-
Heparin therapy for deep venous thrombosis
-
Kashtan J, Conti S, Blaisdell FW. Heparin therapy for deep venous thrombosis. Am J Surg 1980;140:836-40.
-
(1980)
Am J Surg
, vol.140
, pp. 836-840
-
-
Kashtan, J.1
Conti, S.2
Blaisdell, F.W.3
-
34
-
-
0014592649
-
Assessment of anticoagulant treatment of venous thromboembolism
-
Coon WW, Willis PW 3rd, Symons MJ. Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg 1969;170:559-68.
-
(1969)
Ann Surg
, vol.170
, pp. 559-568
-
-
Coon, W.W.1
Willis 3rd, P.W.2
Symons, M.J.3
-
35
-
-
0015514101
-
A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time
-
Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972;287:324-7.
-
(1972)
N Engl J Med
, vol.287
, pp. 324-327
-
-
Basu, D.1
Gallus, A.2
Hirsh, J.3
Cade, J.4
-
36
-
-
84879282614
-
Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
-
Kaplan K, Davison R, Parker M, Mayberry B, Feiereisel P, Salinger M. Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1987;59:241-4.
-
(1987)
Am J Cardiol
, vol.59
, pp. 241-244
-
-
Kaplan, K.1
Davison, R.2
Parker, M.3
Mayberry, B.4
Feiereisel, P.5
Salinger, M.6
-
37
-
-
0024153910
-
Thrombolyse intraveineuse dans l'infarctus du myocarde: Influence de la qualite de l'anticoagulation sur le taux de recidives precoces d'angor ou d'infarctus.
-
Camilleri JF, Bonnet JL, Bouvier JL, et al. Thrombolyse intraveineuse dans l'infarctus du myocarde: influence de la qualite de l'anticoagulation sur le taux de recidives precoces d'angor ou d'infarctus. Arch Mal Coeur 1988;81:1037-41.
-
(1988)
Arch Mal Coeur
, vol.81
, pp. 1037-1041
-
-
Camilleri, J.F.1
Bonnet, J.L.2
Bouvier, J.L.3
-
38
-
-
0038285887
-
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia
-
for the Argatroban-915 Investigators
-
Lewis BE, Wallis DE, Leya F, for the Argatroban-915 Investigators. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 2003;163:1849-56.
-
(2003)
Arch Intern Med
, vol.163
, pp. 1849-1856
-
-
Lewis, B.E.1
Wallis, D.E.2
Leya, F.3
-
39
-
-
0017749446
-
Control and complications of intermittent heparin therapy
-
Norman CS, Provan JL. Control and complications of intermittent heparin therapy. Surg Gynecol Obstet 1977;145:338-42.
-
(1977)
Surg Gynecol Obstet
, vol.145
, pp. 338-342
-
-
Norman, C.S.1
Provan, J.L.2
-
40
-
-
0023614407
-
Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
-
Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987;82:703-13.
-
(1987)
Am J Med
, vol.82
, pp. 703-713
-
-
Landefeld, C.S.1
Cook, E.F.2
Flatley, M.3
Weisberg, M.4
Goldman, L.5
-
41
-
-
0026652032
-
Optimal therapeutic level of heparin therapy in patients with venous thromboembolism
-
Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thromboembolism. Arch Intern Med 1992;152:1589-95.
-
(1992)
Arch Intern Med
, vol.152
, pp. 1589-1595
-
-
Hull, R.D.1
Raskob, G.E.2
Rosenbloom, D.3
-
42
-
-
0020264027
-
A comparison of high-dose versus conventional-dose heparin therapy for deep vein thrombosis
-
Conti S, Daschbach M, Blaisdell FW. A comparison of high-dose versus conventional-dose heparin therapy for deep vein thrombosis. Surgery 1982;92:972-7.
-
(1982)
Surgery
, vol.92
, pp. 972-977
-
-
Conti, S.1
Daschbach, M.2
Blaisdell, F.W.3
|